» Articles » PMID: 2357963

The Inducible Blood--brain Barrier Specific Molecule HT7 is a Novel Immunoglobulin-like Cell Surface Glycoprotein

Overview
Journal EMBO J
Date 1990 Jul 1
PMID 2357963
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The unique properties of brain endothelial cells, which form the blood-brain barrier, are reflected by the expression of specific cell surface molecules. We report here the purification, cloning and expression of one such molecule which is recognized by HT7 monoclonal antibodies. The HT7 antigen is a highly glycosylated 45-52 kd protein localized in brain endothelial cells, kidney epithelial cells and erythroblasts. The protein was purified to homogeneity from plasma membrane proteins isolated from all three sources using immunoaffinity chromatography and reverse phase HPLC. The amino-terminal amino acid sequences of the proteins were found to be identical. Based on amino acid sequence information, specific primers were designed and the polymerase chain reaction was used to obtain a full length cDNA clone. The nucleotide sequence encoded a novel glycoprotein with two C2-like immunoglobulin related domains, one transmembrane domain and a cytoplasmic tail. Expression of the transfected cDNA in COS cells resulted in the appearance of the HT7 antigen on the surface of these cells. On the basis of our results we propose that the protein may be a receptor involved in cell surface recognition at the blood-brain barrier.

Citing Articles

CD147/Basigin Is Involved in the Development of Malignant Tumors and T-Cell-Mediated Immunological Disorders via Regulation of Glycolysis.

Kanekura T Int J Mol Sci. 2023; 24(24).

PMID: 38139173 PMC: 10743398. DOI: 10.3390/ijms242417344.


Pharmacokinetic Parameters of Recombinant Human Cyclophilin A in Mice.

Kalinina A, Grigorieva E, Smirnova A, Kazansky D, Khromykh L Eur J Drug Metab Pharmacokinet. 2023; 49(1):57-69.

PMID: 38040985 DOI: 10.1007/s13318-023-00871-3.


SARS-CoV-2 infects epithelial cells of the blood-cerebrospinal fluid barrier rather than endothelial cells or pericytes of the blood-brain barrier.

Studle C, Nishihara H, Wischnewski S, Kulsvehagen L, Perriot S, Ishikawa H Fluids Barriers CNS. 2023; 20(1):76.

PMID: 37875964 PMC: 10598911. DOI: 10.1186/s12987-023-00479-4.


The protective effect of low-dose minocycline on brain microvascular ultrastructure in a rodent model of subarachnoid hemorrhage.

Gendosz de Carrillo D, Student S, Bula D, Mielanczyk L, Burek M, Meybohm P Histochem Cell Biol. 2022; 159(1):91-114.

PMID: 36153470 PMC: 9899762. DOI: 10.1007/s00418-022-02150-9.


Intravenous injection of cyclophilin A realizes the transient and reversible opening of barrier of neural vasculature through basigin in endothelial cells.

Nakada-Honda N, Cui D, Matsuda S, Ikeda E Sci Rep. 2021; 11(1):19391.

PMID: 34588482 PMC: 8481259. DOI: 10.1038/s41598-021-98163-w.


References
1.
Cunningham B, Hemperly J, Murray B, Prediger E, Brackenbury R, Edelman G . Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing. Science. 1987; 236(4803):799-806. DOI: 10.1126/science.3576199. View

2.
Brendel V, Karlin S . Too many leucine zippers?. Nature. 1989; 341(6243):574-5. DOI: 10.1038/341574a0. View

3.
Rotwein P, Folz R, Gordon J . Biosynthesis of human insulin-like growth factor I (IGF-I). The primary translation product of IGF-I mRNA contains an unusual 48-amino acid signal peptide. J Biol Chem. 1987; 262(24):11807-12. View

4.
Chen C, Okayama H . High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol. 1987; 7(8):2745-52. PMC: 367891. DOI: 10.1128/mcb.7.8.2745-2752.1987. View

5.
Kozak M . An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 1987; 15(20):8125-48. PMC: 306349. DOI: 10.1093/nar/15.20.8125. View